As secondary or monogenic hypertension is relatively rare, most cases of human hypertension are classified as essential hypertension with unknown aetiology.
1 Hypertension is a complex multifactorial and polygenic disorder that is thought to result from the interaction between an individual's genetic makeup and various environmental factors. 2 However, these genetic determinants interacting with environmental factors with a plausible role in producing final phenotype as yet have proved exceedingly difficult to demonstrate.
Throughout the course of unraveling the genetic makeup of human hypertension, the renin-angiotensin-aldosterone system has drawn substantial attention because of its physiological magnitude in cardiovascular homeostasis. 2 At the beginning of this cascade is renin, a protease synthesized by the kidneys, cleaving the precursor angiotensinogen to release angiotensin I, which is further converted into angiotensin II, a potent vasoconstrictor and stimulator of aldosterone release. From the biological and functional points of view, renin has exerted a powerful effect on electrolyte homeostasis and blood pressure regulation. 3 Thus well-characterizing the role of renin may be a clue to elucidating the genetic makeup of essential hypertension. In this study, we sought to evaluate and compare the relationship between the prevalence of hypertension and renin TaqI polymorphism, which is the C to T transition locating 4036 bp upstream from the start codon, in two Chinese populations: one is Han population in rural area of Fangshan district of Beijing and the other is Tibetan population in urban area of Lhasa.
Our study was based on a door-to-door crosssectional design in Fangshan and Lhasa. A total of 3045 subjects in Fangshan and 1387 subjects in Lhasa were preliminarily recruited, of whom only 896 (469 men/427 women) Han and 568 (298 men/ 270 women) Tibetan subjects were considered in this study and all provided informed consent. A group of 447 Han and 333 Tibetan subjects were diagnosed as essential hypertension according to the following criteria: (1) without consanguinity at enrolment; (2) onset of hypertension aged 20-60 years; (3) systolic BP (SBP) X160 mm Hg or diastolic BP (DBP) X95 mm Hg; (4) free of secondary causes of hypertension; and (5) without pharmacological treatment for hypertension. We also included 449 Han and 235 Tibetan unrelated healthy controls. All of the normotensive subjects had no family history of hypertension, diabetes, renal and hepatic diseases; they all had systolic/diastolic BP below 130/ 85 mm Hg and matched hypertensive subjects for area, age and gender. Body weight and height measurements were taken to calculate body mass index (BMI). Plasma triglycerides (TG), total cholesterol (TC), blood urea nitrogen (BUN) and serum creatinine (Scr) concentrations were determined enzymatically using commercially available kits and auto-analyzer. This study was approved by the Ethics Committee of Chinese Academy of Medical Sciences/Peking Union Medical College.
Genomic DNA was extracted from peripheral blood and genotyping for renin TaqI polymorphism was detected using polymerase chain reactionrestriction fragment length polymorphism (PCR-RFLP). PCR primers and conditions were according to a previous report. 4 PCR products were digested with TaqI and separated on 2% agarose gels. Alleles were denoted as T or t, indicating respectively digestion by TaqI or not. The accuracy of RFLP screening method was confirmed by sequencing randomly selected samples and the concordance reached 100% (data not shown).
Statistical calculations were performed using SAS 9.1.3 (Institute Inc., Cary, NC, USA). Means of continuous variables were compared by unpaired t-test. Genotype distribution was tested by HardyWeinberg (H-W) equilibrium law and was analysed by w 2 -test. Univariate and multivariate logistic regression analyses were employed to assess the relationship between hypertension status and TaqI genotype with adjustment for the effects of confounding phenotypes. P-values, odds ratio (OR) and 95% confidence interval (CI) were calculated accordingly. Two-sided Po0.05 was considered statistically significant.
The characteristics and renin TaqI genotype/allele distributions of the study population were shown in Table 1 and TaqI genotype distributions respected H-W equilibrium in both Han and Tibetan hyperten-sive/normotensive subjects, which signified appropriate population selection. The BMI, SBP, DBP, TC, BUN and Scr levels were significantly higher in hypertensive than in normotensive subjects for both populations (all Po0.01). With respect to the TG level, statistical significance was found only in Han population (P ¼ 0.0013). The overall distributions of genotype/allele of renin TaqI polymorphism were significantly different (all Po0.05) between hypertensive and normotensive subjects in both populations, particularly in Tibetan population (both Po0.002). The relative risk associated with t allele was 1.62 (95% CI, 1.18 to 2.23; P ¼ 0.0029) in Han population and 2.06 (95% CI, 1.39 to 3.09; P ¼ 0.0004) in Tibetan population assuming t-dominant model. Additional analysis assuming T-dominant model showed no material as a statistically significant association. Results from multivariate logistic regression analysis after adjustment for age, BMI, TG, TC, BUN and Scr levels showed significant association of renin TaqI polymorphism with increased risk of hypertension in both populations and the adjusted effects were obvious in Han population.
Animal model studies have clearly suggested that variations in renin gene affect blood pressure, and thus are responsible for the development of hypertension. 5 As yet, numerous studies in humans have focused attention on renin intronic polymorphisms, such as HindIII, BglI and MboI, [6] [7] [8] whereas studies regarding the promoter TaqI polymorphism are sparse in the literature. The distributions of TaqI polymorphism have varied greatly among different reports. In our study, the frequency of TaqI t allele in Han population (9.7%) was almost similar to that of Tibetan population (10.0%), which was lower than that in Caucasian European population 9 (13.7%) and in Danmark population 4 (14.6%), and also was exceedingly lower than that in Afro-Caribbean population 9 (28.4%). These discrepancies might be due to differences among ethnic populations and differences in sampling methods. In view of ethnic differences, Izawa et al. 10 have suggested that it is important to construct a database of polymorphisms related to hypertension in each ethnic group.
There are mainly two different sampling methods: hospital-based sampling and population-based sampling. 11 The former might undertake the potentials of admixture and stratification, which increase false-positive errors or confound true-positive detection. In this regard, the present work was based on a door-to-door cross-sectional design in two relatively Research Letter isolated populations. The enrolled Tibetans were all permanent residents of Lhasa city, which has an altitude of 3700 m above sea level. Besides the geographic blocking, the residents seldom intermarried with other ethnic groups. The Fangshan population also offered some important advantages, including high prevalence of hypertension (16.8%), low prevalence of treatment, low divorce rate and limited mobility. 12 On balance, our samples are invaluable for genetic association study.
To the best of our knowledge, this is the first study reporting the association of renin TaqI polymorphism with the prevalence of hypertension in Tibetan population. The renin TaqI polymorphism may be a predisposing factor for hypertension in Han and Tibetan populations assuming t-dominant model, and this predisposing effect is more pronounced in Tibetan population. With respect to different TaqI genotype and BP as quantitative trait, we found that SBP was significantly lower in subjects with TT genotype, higher in tt ( þ 11.03 mm Hg in Han population and þ 10.49 mm Hg in Tibetan population vs TT) genotype and intermediate in Tt ( þ 5.97 mm Hg in Han population and þ 5.10 mm Hg in Tibetan population vs TT) genotype. As for DBP, no material difference was found across TaqI genotype in both populations (data not shown). Thus, we preliminarily hypothesized that renin might correlate with systolic hypertension until replicated in another study.
Here we should recognize as a major weakness of the present study that data on plasma renin levels were not available. Although elucidating the underlying mechanisms is beyond the scope of this study, the speculation that renin TaqI polymorphism might be a genetic marker for hypertension reinforces the need for extensive replication and physiological conformation in different ethnic populations. Moreover, our logistic regression analysis indicated that the confounding effects were obvious in Han population compared with Tibetan population. Given the sample size of the study populations due to the strict selection criteria, these results should be considered preliminary and more studies are warranted to elucidate to what extent these confounding phenotypes influence the speculated association between this polymorphism and hypertension.
In summary, the present study adds evidence that renin might be a physiological mediator-or at least a marker-of some degree of essential hypertension in Han and Tibetan populations. Also these observations leave the question open of whether the mutated TaqI 
